Sorrento Therapeutics Board Member Resigns Citing Lack of Communication on Restructuring

By Ben Glickman

Sorrento Therapeutics said director Tammy Reilly resigned Oct. 25 citing a lack of communication from the bankrupt company’s chief restructuring officer.

The pharmaceutical company said in a regulatory filing Friday that Reilly also cited the “general operating of the company” and modifications to the company’s directors’ and…